Micro data assessment of Russian drug benefit monetization

Journal of Health Organization and Management

Volumn 23, Issue 5, 2009, Pages 465-476

  Besstremyannaya, Galina ^a  

^a CENTRAL ECONOMICS AND MATHEMATICS INSTITUTE   (Russian Federation)

Author keywords

Pharmaceuticals industry; Russia; Social benefits

Indexed keywords

EID: 70350333270     PISSN: 14777266     EISSN: None     Source Type: Journal    
DOI: 10.1108/14777260910983970     Document Type: Article

References (37)

1. (The) Appendix to the Order of Ministry of Health Care and Social Development (2004), No. 296, 2 December (in Russian).
2. Balabanova, D., Mc Kee, M., Pomerleau, J., Rose, R. and Haerpfer, C. (2004), “Health service utilization in the Former Soviet Union: evidence from eight countries”, Part II, Health Services Research, Vol. 39 No 6.
3. Blam, I. and Kovalev, S. (2006), “Spontaneous commercialization, inequality and the contradictions of compulsory medical insurance in transitional Russia”, Journal of International Development, Vol. 18, pp. 407-423.
4. (The) Browsing and Monitoring System of the Russian Federation Social Insurance Fund (2005), available at: http://fz122.fss.ru/index.php?PHPSESSID=7isb606i76tbl3l4p63ji0qn16& service=81§ion=a&nl=1&from=&to=&split=1&sum_cnt=0&B1.x=58&B1.y=8 (in Russian).
5. Chernovisov, G., Zakharova, V., Zhurov, D. and Romanova, S. (2005), “Medical industry in the nine months of 2005”, Remedium, No. 12, pp. 52-63 (in Russian).
6. Denisov, V. (2006), “Medicine decompensation”, Rossijskaya gazeta, Vol. 10, November (in Russian).
7. Expert Journal Investment Ratings (2004), available at: www.raexpert.ru/ratings/regions/2004/ (in Russian).
8. Federal Law of the Russian Federation (2004), Federal Law of the Russian Federation, No. 122, 22 August (in Russian).
9. Flek, V.O. and Reihtman, T.V. (2007), “Additional drug provision for certain groups of citizens: the place and role in the program of state guarantees for free medical care to the citizens of the Russian Federation”, Menedzher zdravoohraneniya, No. 1, pp. 33-41 (in Russian).
10. Ishmukhametov, A. (2006), “Russian pharmmarket: ten years of history and forecast for development”, Remedium, No. 8, pp. 18-21 (in Russian).
11. Kakorina, E.P. and Ivanova, O.I. (2004), “Contemporary problems for providing the access to drugs for various population groups”, Zdravoohranenie Rossijskoi Federatsii, Vol. 4, pp. 11-18 (in Russian).
12. Menedzher zdravoohraneniya (2007), “Development of domestic pharmaceutical industry as an element of stabilizing drug provision”, No. 6, pp. 30-33 (in Russian).
13. Ministry of Health and Social Development (2005), Monitoring of Implementation of the Federal Law No. 122, Ministry of Health and Social Development, Moscow, available at: www.mzsrrf.ru/analit_inform/57.html (in Russian).
14. Ministry of Health and Social Development (2007), Analytical Report on Additional Drug Provision Program, Ministry of Health and Social Development, Moscow (in Russian).
15. Ministry of Health of the Russian Federation and WHO database (n.d.), Implementation of Health Reform in the Subjects of Russian Federation, available at: www.healthreform.ru/stat_data/fin_maps.html (in Russian).
16. NOBUS (2003), NOBUS, available at: http://web.worldbank.org/WBSITE/EXTERNAL/COUNTRIES/ECAEXT/RUSSIANFEDERATIONEXTN/0,contentMDK:20919706∼ menuPK:2560592∼pagePK:1497618∼piPK:217854∼theSitePK:305600,00.html.
17. Podgorbunskih, N.I. and Tolstova, E.V. (2002), “Implementation of guarantees for drug benefit provision for population at the federal level”, Novaya Apteka, No. 4, pp. 27-30 (in Russian).
18. RLMS (2003), RLMS, available at: www.cpc.unc.edu/rlms/.
19. Romanova, S. and Zakharova, V. (2005 a), “Rating of pharmaceutical industry enterprises in the first quarter of 2005”, Remedium, No. 8, pp. 44-53 (in Russian).
20. Romanova, S. and Zakharova, V. (2005 b), “Rating of pharmaceutical industry enterprises in the first half of 2005”, Remedium, No. 11, pp. 52-60 (in Russian).
21. Rudakova, A.V. and Perevozchikov, N.N. (2005), “The structure of drug consumption in the system of additional drug provision: ways for optimization. The example of Petersburg”, Remedium, Vol. 9, pp. 33-43 (in Russian).
22. Shapiro, J. and Besstremyannaya, G. (2002), “The Russian Federation”, mimeo, Healthcare in the Developing World: GDN-Merck Country Studies, Moscow.
23. Social Security Programs throughout the World: Asia and the Pacific (2006), available at: www.ssa.gov/policy/docs/progdesc/ssptw/2006-2007/asia/index.html.
24. Social Security Programs throughout the World: Europe (2006), available at: www.ssa.gov/policy/docs/progdesc/ssptw/2006-2007/europe/index.html.
25. Sokolova, V. and Galuzo, A. (2005), “Pharmaceutical market of the Russian Federation in the first half of 2005”, Remedium, No. 10, pp. 45-48 (in Russian).
26. State Statistical Agency of the Russian Federation (2006), Russian Statistical Yearbook, 2005, State Statistical Agency of the Russian Federation, Moscow.
27. State Statistical Agency of the Russian Federation (2004-2006), Price Index Data in 2004-2006, State Statistical Agency of the Russian Federation, Moscow, available at: www.gks.ru/wps/portal/!ut/p/.cmd/cs/.ce/7_0_A/.s/7_0_3S6/_th/J_0_9D/_s.7_0_A/7_0_2BD/_me/7_0_2BC-7_0_A/_s.7_0_A/7_0_3S6.
28. Street, A., Jones, A. and Furuta, A. (1999), “Cost-sharing and pharmaceutical utilization and expenditure in Russia”, Journal of Health Economics, Vol. 18, pp. 459-472.
29. Summers, L.H. (1989), “What can economics contribute to social policy? Some simple economics of mandated benefits”, AEA Papers and Proceedings, Vol. 79 No. 2, pp. 177-183.
30. Trofimova, E.O. (2005), “Russian pharmaceutical market: reboot of the matrix”, Remedium, No. 7, pp. 64-73 (in Russian).
31. Twigg, J.L. (1998), “Balancing the state and the market: Russia's adoption of obligatory medical insurance”, Europe-Asia Studies, Vol. 50 No. 4, pp. 583-602.
32. Vasserman, V.A. (2001), “Social portrait of patients, endowed the right for drug benefit treatment”, Ekonomika Zdravoohraneniya, No. 11 / 12, pp. 61-64 (in Russian).
33. Volchkova, N., Gorshkova, E., Lobanov, S., Makrushin, A., Tourdyeva, N. and Khaleeva, Y. (2006), Evaluation of the Consequences of Social Reforms: Monetization of Social Benefits and Housing and Communal Services Reform, Moscow Public Science Foundation, Moscow.
34. Witter, S. and Sheiman, I. (1997), “The private sector and ‘privatization’ in health”, in Ed. Witter, S. and Ed. Ensor, T. (Eds), An Introduction to Health Economics for Eastern Europe and the Former Soviet Union, Chichester, pp. 155-164.
35. Zakharova, V. and Romanova, S. (2004), “Rating of pharmaceutical industry enterprises in 2003”, Remedium, No. 4, pp. 62-71 (in Russian).
36. Zakharova, V. and Romanova, S. (2005), “Rating of pharmaceutical industry enterprises in 2004”, Remedium, No. 7, pp. 50-57 (in Russian).
37. Taranov, A.M. and Vasilieba, T.P. (2006), “The System of Health Accounts: Approaches for Formation, Analysis and Forecast at the Federal Level”, in Ed. Taranov, A.M. (Ed.), The System of Health Accounts, Moscow (in Russian).